A Prognostic Index for Patients with Refractory or in First Relapsed Acute Myeloid Leukemia Treated with FLAG-Ida or Flago-Ida

被引：0
|
作者：
Miguel Bergua, Juan [1 ]
Montesinos, Pau [2 ]
Martinez-Cuadron, David [3 ]
Fernandez-Abellan, Pascual [4 ]
Serrano, Josefina [5 ]
Jose Sayas, Maria [6 ]
Prieto-Fernandez, Julio [7 ]
Garcia, Raimundo [8 ]
Julia Garcia-Huerta, Ana [9 ]
Barrios, Manuel [10 ]
Perez-Lopez, Cristina [11 ]
Perez-Encinas, Manuel [12 ]
Siemele, Adriana [13 ]
Rodriguez-Macias, Gabriela [11 ]
Herrera-Puente, Pilar [11 ]
Rodriguez-Veiga, Rebeca [2 ]
Pilar Martinez-Sanchez, Maria [11 ]
Lourdes Amador-Barciela, Maria [13 ]
Sanz, Miguel A. [3 ,14 ,15 ,16 ]
机构：
[1] PETHEMA Cooperat Grp, Caceres, Spain
[2] Hosp Univ & Politecn La Fe, Valencia, Spain
[3] PETHEMA Cooperat Grp, Valencia, Spain
[4] PETHEMA Grp, Spanish Soc Hematol, Badalona, Spain
[5] Hosp Univ Reina Sofia, Cordoba, Spain
[6] PETHEA Cooperat Gropu, Valencia, Spain
[7] Hosp San Pedro de Alcantara Caceres, Caceres, Spain
[8] Hosp Univ Gen Castellon, Castellon de La Plana, Spain
[9] PETHEMA Cooperat Grp, Oviedo, Spain
[10] PETHEMA Cooperat Grp, Malaga, Spain
[11] PETHEMA Cooperat Grp, Madrid, Spain
[12] PETHEMA Cooperat Grp, Santiago De Compostela, Spain
[13] PETHEMA Cooperat Grp, Pontevedra, Spain
[14] HOVON Cooperat Grp, Valencia, Spain
[15] PALG Cooperat Grp, Valencia, Spain
[16] GATLA Cooperat Grp, Valencia, Spain
来源：
BLOOD | 2014年 / 124卷 / 21期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：4
相关论文
共 50 条
  • [21] Retrospective Comparison between MEC and FLAG-Ida Regimens for Refractory or Relapsed Acute Myeloid Leukemia in Adults
    Silva, Wellington F.
    Da Rosa, Lidiane Ines
    Seguro, Fernanda S.
    Silveira, Douglas R. A.
    Nardinelli, Luciana
    Buccheri, Valeria
    Velloso, Elvira D. R. P.
    Rocha, Vanderson
    Rego, Eduardo M.
    BLOOD, 2019, 134
  • [22] FLAG-ida as a stem cell mobilization regimen in patients with primary refractory or relapsed acute leukemia
    Cagirgan, S
    Pehlivan, M
    Donmez, A
    Talu, P
    Yilmaz, M
    Tombuloglu, M
    BONE MARROW TRANSPLANTATION, 2003, 31 : S257 - S257
  • [23] A phase I trial of selinexor plus FLAG-Ida for the treatment of refractory/relapsed adult acute myeloid leukemia patients
    María P. Martínez Sánchez
    Juan Eduardo Megías-Vericat
    Rebeca Rodríguez-Veiga
    Susana Vives
    Juan Miguel Bergua
    Anna Torrent
    Sara Suárez-Varela
    Blanca Boluda
    Joaquín Martínez-López
    Isabel Cano-Ferri
    Evelyn Acuña-Cruz
    Laura Torres-Miñana
    Beatriz Martín-Herreros
    Alfons Serrano
    Amparo Sempere
    Eva Barragán
    Claudia Sargas
    Miguel Sanz
    David Martínez-Cuadrón
    Pau Montesinos
    Annals of Hematology, 2021, 100 : 1497 - 1508
  • [24] A phase I trial of selinexor plus FLAG-Ida for the treatment of refractory/relapsed adult acute myeloid leukemia patients
    Martinez Sanchez, Maria P.
    Megias-Vericat, Juan Eduardo
    Rodriguez-Veiga, Rebeca
    Vives, Susana
    Bergua, Juan Miguel
    Torrent, Anna
    Suarez-Varela, Sara
    Boluda, Blanca
    Martinez-Lopez, Joaquin
    Cano-Ferri, Isabel
    Acuna-Cruz, Evelyn
    Torres-Minana, Laura
    Martin-Herreros, Beatriz
    Serrano, Alfons
    Sempere, Amparo
    Barragan, Eva
    Sargas, Claudia
    Sanz, Miguel
    Martinez-Cuadron, David
    Montesinos, Pau
    ANNALS OF HEMATOLOGY, 2021, 100 (06) : 1497 - 1508
  • [25] FLAG-IDA as frontline induction or salvage therapy for patients with high risk and/or relapsed or refractory acute myeloid leukemia (AML)
    Bhella, Sita
    Atenafu, Eshetu G.
    Schuh, Andre C.
    Minden, Mark D.
    Schimmer, Aaron David
    Gupta, Vikas
    Seftel, Matthew D.
    Alam, Naheed
    Lutynski, Andrzej
    Rydlewski, Anna
    Rostom, Amr
    Yee, Karen W. L.
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [26] Differential Outcomes of Salvage with FLAG-IDA and Venetoclax-Based Regimens in Relapsed and Refractory Acute Myeloid Leukemia
    Bouligny, Ian M.
    Maher, Keri R.
    BLOOD, 2021, 138
  • [27] FLAG/FLAG-IDA regimen for children with relapsed/refractory acute leukemia in the era of targeted novel therapies
    Mustafa, Omima
    Abdalla, Khalid
    AlAzmi, Aeshah A.
    Elimam, Naglla
    Abrar, Mohammed Burhan
    Jastaniah, Wasil
    JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 2019, 25 (08) : 1831 - 1838
  • [28] FLAG-IDA: A HIGHLY EFFECTIVE SALVAGE REGIMEN IN PRIMARY REFRACTORY ACUTE MYELOID LEUKEMIA
    Virijevic, M.
    Suvajdzic-Vukovic, N.
    Djunic, I.
    Novkovic, A.
    Mitrovic, M.
    Colovic, N.
    Vidovic, A.
    Tomin, D.
    HAEMATOLOGICA, 2013, 98 : 520 - 520
  • [29] CPX-351 Versus FLAG-IDA with or without Venetoclax in Previously Untreated and Relapsed or Refractory Acute Myeloid Leukemia
    Baoligny, Panellan
    Murray, Graeme
    Ho, Thuy
    Gor, Juhi
    Zacholski, Kyle
    Wages, Nolan
    Grant, Steven
    Maher, Keri
    BLOOD, 2023, 142
  • [30] TREATMENT OF ACUTE MYELOID LEUKEMIA IN OLDERS WITH AN OUTPATIENT FLAG-IDA PROTOCOL
    Gallarreta, Z. Diez
    Vazquez, G. Perez
    Montes-Gaisan, C.
    Bermudez, A.
    Cuesta, A.
    Yanez, L.
    Lopez-Duarte, M.
    Colorado, M.
    Insunza, A.
    Gutierrez, M.
    Sanroma, P.
    Conde, E.
    Baro, J.
    Richard, C.
    Iriondo, A.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2010, 95 : 274 - 274
12345